Inaugural AHRQ Comparative Review Questions GERD Device Therapy Data
This article was originally published in The Gray Sheet
Executive Summary
Clinical trial data on endoscopic treatments for gastroesophageal reflux disease, or GERD, is not up to par with the available research on pharmaceutical or surgical options, according to the Agency for Healthcare Research & Quality
You may also be interested in...
EndoGastric Solutions Rewrites Playbook In Bid To Build GERD Business
Founded in 2001, EndoGastric Solutions Inc., a mature medical device company with $140 million in venture backing, hasn’t been able to secure a reliable source of reimbursement dollars for its EsophyX endoscopic treatment for GERD. Under new management, EGS is recommitting itself to collecting necessary clinical data and operating as a lean start-up as it makes its case for coverage and reimbursement with insurers.
Research In Brief
GERD endoscopy data still lacking
Research In Brief
GERD endoscopy data still lacking